BAX - Baxter Corp P/S Multiple

Corporate company logo of Baxter Healthcare (BAX)

By diversifying its raw material streams, Baxter International has established an uninterrupted supply of hospital equipment. The company's P/S ratio shows local stabilization, with the metric holding around 1.10. Strict FDA oversight and patent protection create a powerful defensive moat. Management is currently focusing on asset divestiture and debt reduction to restore the investment attractiveness of the core portfolio.

BAX Baxter Corp: P/S Multiple in the range 07/04/2022 - 11/13/2026

Baxter Corp (BAX) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company analysis:BAX, baxter.com
Manufactured products of Baxter International Inc.

The P/S ratio determines the market value of a business relative to its daily revenue, allowing for an assessment of asset monetization efficiency without the time lags associated with financial reporting. By analyzing the P/S multiple trend, an investor compares market expectations with the expansion rates of Baxter International (BAX), which is increasing sales through the digitalization of patient monitoring and the acquisition of new technological portfolios in the dialysis sector.

Competing companies

ISRG (intuitive.com) - Market Capitalization-to-Revenue Ratio|Danaher - Market Cap to Revenue|P/S Multiple BD BDX|STE - Price-to-Revenue Ratio|West Pharma Corp (WST) - Market Cap to Revenue|MASI: P/S Multiple|Price to Sales stevanatogroup.com (STVN)|Price-to-Revenue Ratio Teleflex|Market Cap to Revenue Ratio MMSI (Merit Medical Systems, Inc.)|Market Cap to Revenue NVST (Envista Holdings Corp)|Market Cap to Sales Volume ICUI|Price-to-Revenue Ratio DENTSPLY SIRONA Inc. XRAY|Price-to-Revenue Coefficient lemaitre.com (LMAT)|AtriCure - P/S Multiple|STAA: Price-to-Revenue Ratio|NAGE: P/S Multiple|ZimVie Corp (ZIMV) - P/S Multiple|Market Cap to Revenue ANGO|Market Cap to Revenue Ratio CERS (cerus.com)|Market Cap to Revenue TKNO (Teknova)|Market Cap to Sales Volume MGRM|P/S Multiple STSS (Sharps Technology)|InfuSystem (INFU) - Price to Sales|UTMD - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical Systems)|NYXH (Nyxoah) - Market Cap to Revenue|Microbot Medical, Inc. - Market Capitalization-to-Revenue Ratio|PDEX (Pro-Dex Corp) - P/S Multiple|Zentek Corp (ZTEK) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Elutia Inc. (ELUT)|milestonescientific.com - Market Cap to Revenue Ratio|NEXGEL - Market Cap to Revenue|Market Cap to Sales Volume RVP (Retractable Technologies Inc.)|Harvard Bioscience - P/S Multiple|Price to Sales Femasys Corporation|meihuamed.com (MHUA) - Price-to-Revenue Ratio|Predictive Oncology Inc. - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Callan JMB Inc.|Market Cap to Revenue Ratio ATRI (Atrion Corp.)|P/S Multiple NURO